STAT

FEBRUARY 20, 2024

We hope you have a smashing day and conquer the world. … China has more obese people than anywhere else in the world, and they are increasingly turning to weight-loss drugs to solve the problem , The Wall Street Journal explains. And of course, do keep in touch.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies 95

STAT

SEPTEMBER 19, 2023

Each year, 10 million people fall ill with the disease, which is most prevalent in India, Indonesia, China, and Nigeria. million people die from TB each year, making it the world’s top infectious killer, according to the World Health Organization. Despite being preventable and curable, 1.5

132

132

STAT

NOVEMBER 30, 2022

As the world watches the rare spectacle of protesters challenging China’s authoritarian leadership over its increasingly perplexing “zero Covid” policy, people who study the disease see threats ahead for China — and beyond.

98

98

STAT

OCTOBER 3, 2022

The world, such as it is, keeps spinning. We hope all goes well and that you conquer the world. … Moderna refused to hand over to China the core intellectual property behind the development of its Covid-19 vaccine, leading to a collapse in negotiations on its sale there , The Financial Times reports. But what can you do?

Vaccines 89

Vaccines 89

STAT

MARCH 3, 2023

Next week, hundreds of scientists from around the world will convene in London for an international summit on genome editing. That technology, which enables scientists to easily excise, alter, or replace specific sections of DNA, was awarded the 2020 Nobel Prize for Chemistry. Continue to STAT+ to read the full story…

93

93

STAT

JANUARY 4, 2023

China is underreporting deaths from Covid-19, a senior official of the World Health Organization said Wednesday as he urged use of a broader definition that would more fully capture the mortality impact of the country’s first big wave of Covid infection.

102

102

STAT

AUGUST 16, 2023

… Chinese pharmaceutical companies are developing domestic versions of “miracle” weight-loss drugs as they take on Western drugmakers selling anti-obesity medication in one of the world’s biggest markets , The Financial Times tells us. A U.S.

Research Laboratories 91

Research Laboratories Documentation Pharmaceutical Companies Pharmaceutical Companies 91

PharmaVoice

JUNE 26, 2023

Based on real-world data from patients in China, researchers were able to pinpoint factors that led to recurring infections — and which drug combos helped.

59

59

Fierce Pharma

FEBRUARY 8, 2024

Roche's subcutaneous C5 inhibitor won its world-first approval in China. . | Eisai said uptake of its Biogen-partnered Alzheimer's drug, Leqembi, will likely miss an early launch target. Takeda cut several cancer candidates in its latest pipeline clear-out. And more.

52

52

STAT

NOVEMBER 21, 2022

The world is fast approaching the third anniversary of those days when we got our first inkling that a new disease was spreading in China. In the months that followed, normal life was suspended, then upended. At this point, everyone is well and truly sick of Covid-19 and the accommodations we have had to make to co-exist with it.

105

105

Pharmaceutical Technology

JUNE 9, 2023

This marks the world’s first Covid-19 vaccine approved for emergency use against XBB descendent lineages of SARS-CoV-2. The vaccine has been developed by WestVac Biopharma along with the West China Medical Center and Sichuan University. recombinant Covid-19 trivalent (XBB.1.5+BA.5+delta) 5+delta) protein vaccine (Sf9 cell).

Vaccines 107

Vaccines 107

Pharmaceutical Technology

MAY 8, 2023

The collaboration will help in further development of BB-1701 across the world and advance the ADC towards late stage of development. Currently, BB-1701 is being evaluated in Phase I/II trials in China and the US. This deal also includes option rights for a strategic collaboration.

98

98

European Pharmaceutical Review

NOVEMBER 29, 2023

For the first time, companies across the global healthcare sector, including AstraZeneca , GSK, Novo Nordisk and Roche, have united to discuss with energy providers in China and India, about scaling renewable power across their supply chains. As part of the Task Force, Novartis and Lonza are working to secure renewable power in China.

83

83

Pharmaceutical Technology

MAY 22, 2023

SinoMab BioScience intends to commence a Phase I clinical trial in China to evaluate SM17’s safety profile. The acceptance of the IND application for SM17 not only accelerated the company’s clinical development project for the treatment of asthma indications in China, but also demonstrated the high efficiency of our new drug development.

Immunization 109

Immunization 109

European Pharmaceutical Review

DECEMBER 13, 2023

Bristol Myers Squibb will also assume sole responsibility for development and commercialisation of the ADC in the rest of the world, outside of Mainland China. SystImmune, through its affiliates, will develop, commercialise and manufacture of BL-B01D1 in Mainland China.

72

72

pharmaphorum

AUGUST 5, 2022

Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring two new cancer therapies as quickly as possible to patients in the world’s second-largest pharma market. The post Sanofi looks east with €300m Innovent cancer alliance appeared first on.

FDA 99

FDA 99

Pharmaceutical Technology

DECEMBER 20, 2022

Biotechnology firm LianBio has announced that Pfizer opted in to secure the right to develop and commercialise the respiratory syncytial virus (RSV) therapeutic candidate, sisunatovir, in Mainland China, Hong Kong, Macau, and Singapore. Pfizer acquired ReViral along with its portfolio of RSV therapeutic candidates in June this year.

Vaccines 64

Vaccines 64

Pharma Mirror

JUNE 8, 2022

According to the Endpoints ASCO session: “China and the US are the world’s largest oncology research destinations, and the. The post Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China appeared first on Pharma Mirror Magazine.

52

52

STAT

MARCH 14, 2024

We hope you have a smashing day and conquer the world. … The Biotechnology Innovation Organization, the industry trade group, is cutting ties with China’s WuXi in response to increasing U.S. Meanwhile, here are few items of interest for you to peruse. And as always, we hope you keep in touch.

106

106

pharmaphorum

JANUARY 20, 2022

According to the World Health Organization, it is defined as the use of ICT to improve patient outcomes by increasing access to care and medical information, incorporating new advancements in technology and responding and adapting to the changing health needs and contexts of societies.

97

97

Viseven

JUNE 12, 2023

Though we’re witnessing fundamental changes all over the world, each region has its peculiarities dictated by multiple local factors. The most distinctive characteristic of pharma companies in APAC from pharma companies in the rest of the world is the domination in the clinical trials market. What’s Next for Customer Experience? —

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

Roots Analysis

FEBRUARY 27, 2024

What are the key terms of the agreement: NovoCodex is responsible for developing and commercializing ARX305 in China while Ambrx is responsible for developing and commercializing ARX305 outside of China. NovoCodex is also eligible to share an undisclosed portion of ARX305 product sales outside of China.

40

40

Pharmaceutical Technology

APRIL 6, 2023

Singapore has therefore become the second country to accept the NDA, following mainland China in November 2022. Renal disease is a key focus area for Everest, and disease prevalence in Asia is much higher than in other areas of the world. Nefecon expects to secure NDA approval in Singapore this year.

52

52

Pharmaceutical Technology

JUNE 14, 2023

The therapy has already been approved to treat atypical haemolytic uraemic syndrome, paroxysmal nocturnal haemoglobinuria and certain gMG adult patients in the US, Japan, the EU and China. We are proud to offer Soliris in China, a first-in-class C5 complement inhibitor and a globally established treatment for gMG. “We

Labelling 52

Labelling Immunization 52

PharmaShots

MAY 15, 2023

The companies collaborated to research and develop oligonucleotide compounds for the treatment of liver disease Amoytop to get an option to obtain an exclusive license for the development and commercialization of the resultant products in the Greater China territory while Aligos will retain rights in the rest-of-world The collaboration will leverage (..)

Compounding 40

Compounding 40

ISPE

MARCH 28, 2023

Summit host: Mr. Gao Xiaowei, Vice President/General Manager of Canton Biologics Mr. Zhang Ping, Chairman of the SPIC China Committee, Ms. Lynn Wang, Chairman of the Pharmaceutical Supply Chain Subcommittee of the SPIC China Committee, and Ms. Cao Yan from SPIC attended the conference online and delivered welcome speeches.

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

pharmaphorum

JUNE 8, 2021

“At present, innovation resources in most Asian countries and regions have not been translated into a sizeable global market share; neither the world nor the local countries and regions have fully benefited from the innovative activities of biopharmas in this region,” he says. of the oncology market in China in 2019, compared to 17.1%

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

ISPE

MARCH 28, 2023

2022 ISPE China Pharmaceutical Supply Chain Summit Trudy Patterson Tue, 03/28/2023 - 09:24 iSpeak Blog iSpeak 2022 ISPE China Pharmaceutical Supply Chain Summit 28 March 2023 On 17 December 2022, more than 100 people from all over the world gathered online for the 2022 ISPE China Pharmaceutical Supply Chain Summit.

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

pharmaphorum

DECEMBER 8, 2021

China’s Shanghai Henlius Biotech says its experimental PD-1 inhibitor serplulimab has extended survival when added to chemotherapy in a phase 3 trial as first-line therapy for extensive stage small cell lung cancer (ES-SCLC), setting up regulatory filings.

Chemotherapy 97

Chemotherapy 97

pharmaphorum

FEBRUARY 15, 2022

One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study. The post Pharma pollution ‘threatens world environment, health’; study appeared first on. The research is published in the Proceedings of the National Academy of Sciences journal.

Compounding 105

Compounding 105

European Pharmaceutical Review

AUGUST 19, 2022

Based on region, China, the world`s second largest economy, is forecast to reach a projected market size of $21.1 The major markets, the US, Canada, Japan, China and Europe, accounted for $8 billion worth of the market in 2020 and are anticipated to reach $11.3 Within the $130.2 billion, growing at a CAGR of 4.4 percent CAGR.

Packaging 90

Packaging Compounding 90

pharmaphorum

FEBRUARY 8, 2021

China plans to provide 10 million doses to the World Health Organization-backed COVAX for every country in the world. The post China approves Sinovac’s coronavirus vaccine appeared first on. Filling and finishing will also be outsourced to overseas partners.

Vaccines 75

Vaccines Immunization 75

Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, Shunxi will have licence to develop, manufacture, and commercialise CTH-004 to treat several solid tumours including ovarian cancer in Greater China, including Hong Kong, Taiwan, Mainland China, and Macao. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

52

52

ISPE

AUGUST 30, 2023

China Forum As a global organization, ISPE is proud to feature their "China Forum". This enlightening workshop will focus on the dynamic pharmaceutical and healthcare landscape in China. Explore the burgeoning realm of Gene and Cell Therapy in China, complete with crucial regulatory insights.

Documentation 98

Documentation Vaccines 98

Pharma Mirror

DECEMBER 9, 2022

The increase in visitor numbers was all the more impressive because many visitors from China – who usually make up around 10% of the show’s in person audience – were prevented from attending. Final visitor numbers will be confirmed by independent auditors ABC in early 2023.

52

52

Pharma Mirror

APRIL 27, 2021

Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment.

52

52

Pharmafile

MARCH 30, 2023

NASDAQ: AQST) for its patented diazepam buccal film formulation to cover rest of the world, excluding US, Canada and China. read more

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40